The FDA announced on March 25, 2014, that Hospira Inc. voluntarily recalled Demerol meperidine HCL Inj. USP ampoules due to missing immediate container labels. The recall affects 237,850 units distributed nationwide.
How to tell if you have it
- Brand: Hospira
- Product: Demerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules
- NDC: 0409-1203-01
- Lot: 221303A
- Expiration date: 1OCT2014
The hazard
The ampoules are missing the immediate container label, which constitutes a labeling hazard. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show Hospira Inc. has issued 108 other recalls since April 5, 2012. Other recent recalls of similar products include American Regent Levocarnitine Injection Recall (April 16, 2026) and Nephron Albuterol Inhaler (March 17, 2026).